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Bioengineering of fetal membrane repair
Abstract
Preterm premature rupture of the foetal membranes (früher vorzeitiger Blasensprung) has remained a
devastating complication of pregnancy with very high risk of pregnancy loss. Several methods of
sealing spontaneously ruptured membranes to stop amniotic fluid leakage and prolong pregnancy have
been tested, but no one of them has achieved a clinical breakthrough. Also, needle and foetoscopic
puncture of membranes for diagnostic or surgical interventions in the amniotic cavity carry a significant
risk of persistent membrane leakage and subsequent rupture - thus limiting the developing field of
intrauterine foetal surgery. Efforts are concentrated on taking action before rupture rather than reacting
after rupture: one avenue of research concerns prophylactic plugging of foetoscopic access sites in foetal
membranes at the time of intervention, thus inhibiting leakage and rupture. Foetal membrane injuries,
spontaneous or iatrogenic, constitute extreme challenges to repair: thinness of foetal membrane tissue,
difficult localisation and accessibility of the rupture site, the need for injectable sealants, wet gluing
conditions and poor wound healing in this tissue all complicate repair. The goal is to achieve immediate
and at the same time long-lasting closure of the membrane leak. Here we review approaches to closure
of foetal membrane defects with liquid sealants or solid biomaterial scaffolds, with the focus on
prophylactic plugging of foetoscopic access sites.
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Preterm premature rupture of the foetal
membranes (früher vorzeitiger Blasensprung) has
remained a devastating complication of preg-
nancy with very high risk of pregnancy loss. Sev-
eral methods of sealing spontaneously ruptured
membranes to stop amniotic fluid leakage and
prolong pregnancy have been tested, but no one
of them has achieved a clinical breakthrough.
Also, needle and foetoscopic puncture of mem-
branes for diagnostic or surgical interventions in
the amniotic cavity carry a significant risk of per-
sistent membrane leakage and subsequent rupture
– thus limiting the developing field of intrauterine
foetal surgery. Efforts are concentrated on taking
action before rupture rather than reacting after
rupture: one avenue of research concerns prophy-
lactic plugging of foetoscopic access sites in foetal
membranes at the time of intervention, thus in-
hibiting leakage and rupture. Foetal membrane
injuries, spontaneous or iatrogenic, constitute ex-
treme challenges to repair: thinness of foetal
membrane tissue, difficult localisation and acces-
sibility of the rupture site, the need for injectable
sealants, wet gluing conditions and poor wound
healing in this tissue all complicate repair. The
goal is to achieve immediate and at the same time
long-lasting closure of the membrane leak. Here
we review approaches to closure of foetal mem-
brane defects with liquid sealants or solid bioma-
terial scaffolds, with the focus on prophylactic
plugging of foetoscopic access sites. 
Key words: spontaneous PPROM; iatrogenic
PPROM; tissue sealants; foetoscopy, injectable hydro-
gel; scaffolds 
Summary
The foetal membranes, consisting of amnion
and chorion, constitute an ~0.5 mm thin layer
surrounding the amniotic cavity. They hold the
amniotic fluid and guard the foetus against infec-
tion ascending the genital tract [1]. Mechanical
rupture of the membranes is part of the natural
sequence of term delivery, but has serious compli-
cations when rupture occurs prior to term;
preterm premature rupture of the foetal mem-
branes accounts for some 30% of premature
births [2]. Histology indicates that the mem-
branes possess a morphologically predefined
“breaking site” over the cervical ostium for rup-
ture [3, 4]. However, this site appears prone to
spontaneous rupture before the onset of labour.
Spontaneous preterm premature rupture of the
membranes (sPPROM) before 37 weeks of gesta-
tion in the absence of labour affects 1–4% of
pregnancies and accounts for 30–40% of preterm
deliveries [5, 6]. It usually occurs in the second
half of pregnancy. Rescue of pregnancy demands
immediate sealing of the amniotic sac. Though
several methods of sealing exist (see below), none
have been found to be really effective. Current
management of sPPROM is immediate delivery
or termination of pregnancy. In surviving infants
morbidity is often severe and includes chronic
lung disease and neurological sequelae such as
blindness, cerebral palsy, white matter damage
and periventricular leukomalacia. Intrauterine in-
fection and inflammation are the likely triggers of
sPPROM, but the pathological sequence leading
to rupture of the membranes is not well under-
stood. At the molecular level, sPPROM appears
to be the result of diminished extracellular matrix
(ECM) synthesis, alterations in the structure of
collagen fibrils and increased ECM degradation.
A point to note is that it is not clear whether in-
fection and inflammation precede defects in the
extracellular matrix or vice versa. 
Diagnostic or surgical invasions of the amni-
otic cavity with needles or foetoscopes pose a risk
of persistent leakage and subsequent premature
preterm rupture of foetal membranes (iatrogenic
PPROM; iPPROM). The most frequent invasion
in clinics, mid-trimester genetic amniocentesis, is
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associated with rupture in only a small number
(approx. 0.5%) of patients. Hence punctures from
amniocentesis are certainly no targets for prophy-
lactic plugging, but plugging could be tried in
those cases where leakage after amniocentesis
persists. In some cases rupture after amniocente-
sis seems due not to the intervention itself but to 
a preexisting subclinical intraamniotic infection.
Several studies have shown that a foetal inflam-
matory response, defined by elevated amniotic
fluid levels of pro-inflammatory cytokines (e.g.
interleukin-6), matrix metalloproteinase-8 or C-
reactive protein at the time of amniocentesis are
associated with an increased risk of spontaneous
preterm delivery [7–10]. 
Thanks to advances in fiber endoscopes, 
operative foetoscopy on foetus and placenta has
become a therapeutic option [6, 11]. Examples are
foetoscopy-guided laser coagulation for foeto-
foetal transfusion syndrome, umbilical cord liga-
tion, and percutaneous endoluminal tracheal oc-
clusions for isolated congenital diaphragmatic
hernia. These invasive procedures are usually per-
formed in the second trimester of pregnancy. A
common complication is persistent leakage of
amniotic fluid from punctured sites, which may
result in preterm delivery [12]. Despite the fact
that these procedures are usually performed via a
single intrauterine entry, rupture from puncture
occurs in 5–30%. Hence iPPROM presents a se-
rious limitation for the developing field of in-
trauterine foetal surgery. 
The technical as well as biological obstacles
for closure of injured foetal membranes are mani-
fold and extreme: thinness of the foetal mem-
brane tissue, difficult localisation and accessibility
of the rupture site in the uterine cavity, large 
lesions in the several-centimeter range, poor 
demarcation of wound edges, the need for in-
jectable sealants, wet gluing conditions etc, com-
plicate repair. Moreover, histology indicates that
wound repair is poor or absent in foetal mem-
brane tissue [13], which adds to the difficulty of
obtaining stable integration of material plugs
grafted into ruptured membranes over weeks or
months. Here we review experimental and early
clinical attempts to close and prevent ruptured
foetal membranes. 
Characteristics of foetal membrane wounds 
Iatrogenic and spontaneous foetal membrane
wounds differ in location and appearance (see [5]
for comprehensive review) and therefore also in
the technical routes for their access and sealing.
Illustrations of Figures 1A-C reflect current evi-
dence. Endoscopic visualisations of spontaneous
Figure 1
Characteristics of foetal membrane wounds on current evidence. (A) Spontaneous membrane ruptures seem to occur at 
a predefined, natural breaking site in the cervical region of the foetal membranes [4]. Spontaneous ruptures are poorly 
demarcated wounds in the several-centimeter range. (B, C) Iatrogenic wounds. (B) Foetoscopic access leads to small-sized
wounds in the few-millimeter range in foetal membranes. The wound site is only known at the time of the intervention. (C)
Rupture from iatrogenic puncture. According to [5], iatrogenic ruptures may be more cleanly delineated than spontaneous
ruptures. Prophylactic plugging of foetoscopic access sites may inhibit membrane leakage iatrogenic rupture. (D) Ex vivo
simulation of iatrogenic rupture from puncture. A needle puncture wound of 1.4 mm diameter was created in fresh foetal
membranes collected from a term pregnancy. Upon mechanical stretching, the foetal membranes rupture from the site 
of the puncture. A cleanly delineated wound of several centimeters in size develops.
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rupture sites in humans show large, torn wounds
in the several-centimeter range over the cervical
ostium [14], possibly corresponding to the prede-
fined ‘breaking site’ in the cervical region of foetal
membranes [4] (fig. 1A). Wound edges were
found to roll, resulting in irregular wounds that
will be even more difficult to seal; this adds an-
other reason for avoiding any time lapse between
rupture and sealing. Iatrogenic ruptures in the
foetal membranes locate to needle insertion sites.
According to [5], ruptures from punctures are
smaller and more cleanly delineated than sponta-
neous ruptures (fig. 1C). Histological followup in-
dicates that puncture wounds in the foetal mem-
brane tissues do not close by growth of new tissue
[13, 15]. Rather, spontaneous closure can be at-
tributed to sliding of amnion and chorion relative
to each other, contraction, or reattachment of the
foetal membranes to the decidual layer of the
uterine wall [13]. The size of iatrogenic mem-
brane defects, and thus the chance of rupture, in-
crease with instrument size. The initial defect size
may range from a typical 20–22 gauge perforation
in the case of amniocentesis up to a 2–5 mm stab
wound from trocars used in operative foetoscopy
[16]. Foetoscopic punctures therefore carry a sig-
nificantly higher risk of rupture [5]. Figure 1D
shows an ex vivo simulation of iatrogenic rupture
in fresh human foetal membranes from a 1.4 mm
puncture after mechanical stretch. In this dra-
matic case, ripping of the foetal membranes from
the puncture site resulted in a cleanly delineated
wide open wound of several centimeters in length,
which at this point has probably become impossi-
ble to reseal. Plugging of foetoscopic access sites
at the time of intervention, as illustrated in fig. 1B,
may inhibit leakage and subsequent rupture. 
Methods of closure after rupture 
Since the early 1990s, clinical attempts have
been made to stop fluid leakage after sPPROM or
iPPROM by physically plugging the cervix or the
membrane defect with liquid sealants or solid
scaffolds. An appealing and clinically practical
strategy was to inject blood clotting agents to
form a blood clot patch in the cervix or directly at
the lesioned membrane in situ [17]. For example,
sealing of sPPROM was approached by delivery
of maternal platelets mixed with fibrinogen solu-
tion via intraamniotic instillation or foetoscopic
application (“amniopatch” [18]), and intracervical
application of a clinical off-the-shelf preparation
of “fibrin glue” [19]. One centre in the US re-
ported an approximately 50% success rate with
“amniopatch” sealant in the treatment of iP-
PROM [20], but these data await confirmation
from other centres. Young et al. reported success-
ful closure of post-amniocentesis ruptures by en-
doscopy-guided sequential injection of platelets,
fibrin, and powdered collagen slurry in 3 of a total
of 4 human cases [12]. Scaffolds have also occa-
sionally been tried for closure of spontaneously
ruptured membranes in human cases with highest
risk of pregnancy loss. This includes one case of
endoscopic placement of a collagen plug (“am-
niograft”) over the membrane defect over the in-
ternal os for sPPROM at gestational week 17 [21],
or cervical plugging with a gelatin sponge for
sPRROM before 21 weeks [22]. In the case of am-
niograft, leakage recurred after 14 days but the
pregnancy continued till week 30. In the gelatin
sponge study 8 of 14 foetuses survived but showed
musculoskeletal abnormalities [22]. Although
early clinical experience indicates the feasibility of
treating iPPROM, no treatment has been imple-
mented in clinics. New material innovations for
sealing remain in great demand in the field. Key
requirements for closure are low resorption and
long-term engraftment of tissue adhesives and
scaffolds respectively. There are no animal models
for spontaneous rupture of foetal membranes, in
contrast to iatrogenic rupture (see below). New
treatment solutions validated for iPPROM may
be tried subsequently for spontaneous PPROM. 
Methods of closure before rupture 
The overall objective is to minimise the risk
of membrane rupture from puncture. One avenue
of research concerns prophylactic sealing of foe-
toscopic access sites in foetal membranes in order
to inhibit amniotic fluid leakage and iPPROM.
The idea is to deploy the plug material into the
puncture site before the fetoscope is finally re-
trieved. The method of sequential injection of
platelets, fibrin glue and powdered collagen slurry
used after membrane rupture [12] has also proved
successful for prophylactic treatment. In a small
clinical study by Young et al., injection of such a
mix directly to the puncture site successfully pre-
vented amniotic fluid loss after an endoscopic
procedure [23]. To date, however, most experience
is preclinical and has been largely acquired in the
rabbit model at midgestation. Though the rela-
tionship of the foetal membranes to decidua and
myometrium in rabbits differs greatly from that in
humans, surgically induced membrane defects
596-601 Zisch 11997.qxp  8.10.2008  7:51 Uhr  Seite 598
599S W I S S  M E D  W K LY 2 0 0 8 ; 13 8 ( 4 1 – 4 2 ) : 5 9 6 – 6 01  ·  w w w. s m w. ch
that are left uncovered will persist in most cases
and lead to oligohydramnios and its implications
for foetal development. Amniotic integrity, amni-
otic fluid volume and foetal survival are the main
parameters for measuring treatment perform-
ance. Solid scaffolds made of collagen, the main
constituent in the ECM of foetal membranes, and
also synthetic polymer plugs were tested in this
model (table 1). In 1999, Deprest et al. demon-
strated the technical feasibility of foetoscopically
deploying collagen plugs for coverage of foeto-
scopic puncture defects on surgically exposed am-
nion sacs in the rabbit model [24]. Thereafter,
foetoscopy-guided insertion of solid collagen
plugs into the punctured membrane (‘champagne
cork method’, see fig. 2), sealing with fibrin, and
surgical closure of myometrium by suture were
tried as individual methods and in combination to
restore amniotic integrity after foetoscopy. Each
method alone did not exhibit any significant ben-
efit for restoration, but the combination of colla-
gen plug with myometrial suture finally proved
successful [25]. Importantly, the latter technique
applied with a gelatin sponge also proved effective
for long-term closure of foetoscopic access sites
in sheep and rhesus monkeys, which have gesta-
tional periods of 145 and 165 days respectively
[26]. Endoscopy showed that the inserted gelatin
sponge rapidly swells through fluid absorption
and self-locks in the membrane defect.
Study Plugging material Animal Improved amniotic 
integrity
Papadopulos et al. (1998) [16] Collagen (Colgen®) rabbit No 
Deprest et al. (1999) [24] Collagen (Colgen®) rabbit No 
Luks et al. (1999) [26] Gelatin sponge (Gelfoam) sheep All foetuses survived till
+ myometrial suture the ewes were killed near term 
Luks et al. (1999) [26] Gelatin sponge (Gelfoam) rhesus 3 out of 5 foetuses survived till
+ myometrial suture monkey spontaneous delivery 
Gratacos et al. (2000) [25] Collagen (Colgen®) rabbit Yes
+ myometrial suture
Gratacos et al. (2000) [25] Matrigel rabbit No
+ myometrial suture
Devlieger et al. (2003) [36] Porcine small intestine (bioSIS) rabbit Yes  
contains transforming growth factor-b
and basic fibroblast factor  
Papadopulos et al. (2006) [27] Collagen (TissueFoil E®) rabbit Yes
+ fibrin sealant
+ myometrial suture
Papadopulos et al. (2006) [27] Tissue banked human amnion membrane rabbit No 
+ fibrin sealant
+ myometrial suture
Papadopulos et al. (2006), Collagen foil (TissueFleece®) rabbit Yes
Mallik et al. (2007) [15, 27] + fibrin sealant
+ myometrial suture
Mallik et al. (2007) [15] Decellularized human amnion rabbit Yes
+ fibrin sealant
+ myometrial suture
Ochsenbein-Kölble et al. (2007) [32] Decellularized rabbit amnion rabbit Yes
+ myometrial suture
Ochsenbein-Kölble et al. (2007) [32] Polyestherurethane (Degrapol) rabbit Yes
Table 1
Plugs for closure of
foetoscopic access
sites.
Figure 2
Plugging foetoscopic access sites in foetal membranes with scaffolds. (A) The prophylactic plugging approach, here illus-
trated with a champagne cork inserted into a large foetal membrane defect, aims to create a physical barrier to amniotic fluid.
(B) Deployment of plugs made of decellularized human amnion is a potential practical surgical method to seal foetoscopic 
access sites [15, 32]. Human amnion is a readily accessible, unique source of human collagen matrix. The 0.2 mm thin, blood
vessel-free amnion is an ideal tissue for decellularisation which renders human amnion non-immunogenic. The decellularised
amnion sheet is inserted as a compacted plug that self-locks in the foetal membrane wound.
Foetoscopic 
insertion 
into foetal
membranes
Compacted
amnion plug
Decellularized
amnion sheet
Collection of amnionBA
596-601 Zisch 11997.qxp  8.10.2008  7:51 Uhr  Seite 599
600Foetal membrane repair
The common notion of low or absent
anatomical repair and poor plug engraftment in
foetal membranes has prompted biological re-
search to activate repair. We, like others, have
considered supplying growth factors or amnion
cells in the graft material to enhance cell migra-
tion and graft colonisation, i.e. a concept of tissue
engineering for foetal membrane repair [27–30].
In line with this idea, we used collagen gel and
fibrin gel matrices seeded with amnion epithelial
and mesenchymal cells to mimic natural amnion
tissue in vitro [29]. This showed fibrin gel to be
principally suitable for amnion cell grafting, but it
is resorbed too quickly. Collagen gels seeded with
amnion mesenchymal cells showed dramatic con-
traction, which would probably cause rapid loss of
the plug from the defect. As an alternative we in-
troduced decellularised collagen scaffolds pro-
duced directly from human amnion, with the idea
that native matrix might integrate better [15, 31,
32]. Human amnion tissue constitutes a readily
accessible and unique source of human ECM. Be-
cause the amnion layer of human foetal mem-
branes is only 0.2 mm thin and lacks blood ves-
sels, it is an ideal starting tissue for manufacture
of sheets of cell-free ECM. It is well established
that removal of cellular components renders allo-
geneic and xenogeneic tissue non-immunogenic
[33]. Figure 2 shows the sequence of amnion plug
preparation. Two independent trials in rabbits
suggest that foetoscopic deployment of decellu-
larised amnion plugs to be a surgically practical
method for closure of foetoscopic access sites [15,
32]. Once released from the fowetoscope into the
lesion, the compacted plug relaxes and self-locks
into the lesion. There was no evidence of incipi-
ent anatomical remodeling of the plug into foetal
membrane tissue. Decellularised amnion plugs
involve several benefits for applications in the
clinic, as they exhibit superior surgical handling
characteristics, are easy to manufacture, are non-
immunogenic and biocompatible, and are suitable
for storage and transport for off-the-shelf use.
Further studies are necessary to validate the safety
and long-term functionality of cell-free amnion
plugs.
Limitations
Major limitations concern the animal models
for foetal membrane repair. The anatomy of foetal
membranes in human and non-human primates is
unique. Potential maternal problems arising from
intervention with plugs, such as adhesions, are
likely to be absent in the rabbit and sheep models.
In the case of prophylactic plugging, the human
situation requires the plug to be applied by percu-
taneous needle foetoscopy, and to last in the de-
fect for several weeks or months. But neither per-
cutaneous needle foetoscopy nor long-term fol-
lowup is possible in the rabbit model (as discussed
by us in [15]). Hence studies in non-human pri-
mates or sheep with longer gestational periods
will be needed to resolve whether durable sealing
with plugs can be achieved. Stable integration and
a low resorption rate are all areas of research for
the near future. Foetoscopic grafting of solid
plugs may be suitable for closure of focal defects
in the foetal membranes, but probably not for
larger, undefined defects as produced on sponta-
neous PPROM.
Conclusions
For biological and technical reasons foetal
membrane wounds are extremely difficult to treat.
So despite  the magnitude of this problem in ob-
stetrics, only a few centres worldwide have taken
up the challenge of foetal membrane repair. How-
ever, prevention of rupture from puncture by
plugging at the time of foetoscopic intervention
appears to be feasible. In addition to solid plugs of
collagen or cell-free amnion matrix, innovations
in the field of injectable, in situ-forming synthetic
polymer hydrogel sealants offer new options for
sealing of iatrogenic puncture wounds. These in-
clude the bioinspired DOPA-based hydrogel
mimetics of mussel adhesives [34] or photopoly-
merisable poly(ethylene glycol) hydrogel barriers
[35]. It remains to be seen whether such poly-
meric hydrogel sealants can fulfill their barrier
function long-term on fast growing human foetal
membranes. The emerging evidence seems to
militate against the concept of regenerating defec-
tive foetal membranes at the anatomical level.
However, studies in non-human primates or
sheep are needed to resolve whether the concepts
of mere physical plugging are more advantageous
than the “living tissue engineering concept”. We
believe that the future selection criteria for candi-
date sealants for foetal membrane repair may be
narrowed to their potential as an immediate, sta-
ble, non-toxic physical barrier to amniotic fluid. 
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